Publications by authors named "Mark Meininghaus"

Claim this Profile
D
Discovery of BAY 2413555, First Selective Positive Allosteric Modulator of the M2 Receptor to Restore Cardiac Autonomic Balance.
Alexandros Vakalopoulos, Daniel Basting, Markus Brechmann, Henrik Teller, Melissa Boultadakis Arapinis, Mark Meininghaus

J Med Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Shot Solid-Phase Synthesis of Full-Length H2 Relaxin Disulfide Surrogates.
Rui Zhao, Pan Shi, Ji-Bin Cui, Chaowei Shi, Xiao-Xiong Wei, Mark Meininghaus

Angew Chem Int Ed Engl· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Selective optogenetic control of G signaling using human Neuropsin.
Ahmed Wagdi, Daniela Malan, Udhayabhaskar Sathyanarayanan, Janosch S Beauchamp, Markus Vogt, Mark Meininghaus

Nat Commun· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective optogenetic control of G signaling using human Neuropsin.
Ahmed Wagdi, Daniela Malan, Udhayabhaskar Sathyanarayanan, Janosch S Beauchamp, Markus Vogt, Mark Meininghaus

Nat Commun· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and Characterization of Relaxin Family Peptide Receptor 1 Variants.
David Speck, Gunnar Kleinau, Mark Meininghaus, Antje Erbe, Alexandra Einfeldt

Front Pharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF).
Hartmut Beck, Tobias Thaler, Daniel Meibom, Mark Meininghaus, Hannah Jörißen

J Med Chem· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis